Skip to content
10-Q

Quarterly Report

QLY BIOTECH GROUP CORP.

0001376474-20-000080

← back to feed
Filed
Apr 9, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Apr 7, 2020 3M sh
Current Liabilities Q2 2020 · Feb 29, 2020 $7.8K
Current Liabilities Q2 2020 · Aug 31, 2019 $2.98K
Total Liabilities Q2 2020 · Feb 29, 2020 $7.8K
Total Liabilities Q2 2020 · Aug 31, 2019 $2.98K
Current Assets Q2 2020 · Feb 29, 2020 $3.36K
Current Assets Q2 2020 · Aug 31, 2019 $5K
Total Assets Q2 2020 · Feb 29, 2020 $7.92K
Total Assets Q2 2020 · Aug 31, 2019 $5K
Cost Of Revenue Q2 2020 · Feb 29, 2020 $1.4K
Cost Of Revenue Q2 2020 · Feb 29, 2020 $1.4K
Cost Of Revenue Q2 2020 · Feb 28, 2019 $0
Cost Of Revenue Q2 2020 · Feb 28, 2019 $0
Capex Q2 2020 · Feb 28, 2019 $0
Operating Cash Flow Q2 2020 · Feb 28, 2019 −$978
Cash And Equivalents Q2 2020 · Feb 28, 2019 $5K
Cash And Equivalents Q2 2020 · Sep 19, 2018 $0
Sga Expense Q2 2020 · Feb 28, 2019 $0
Sga Expense Q2 2020 · Feb 28, 2019 $978
Net Income Q2 2020 · Feb 28, 2019 $0
Net Income Q2 2020 · Feb 28, 2019 −$978
Revenue Q2 2020 · Feb 28, 2019 $0
Revenue Q2 2020 · Feb 28, 2019 $0